mechanism 3,582 words KG: lysosomal dysfunction
Contents

Lysosomal Dysfunction in Neurodegeneration

Mechanism Info
Namelysosomal dysfunction
Key Genes/Proteinsamyloid-beta, AMYOTROPHIC LATERAL SCLEROSIS, APOE4, AR, C3, C9orf72
Related Diseasesalpha-synuclein aggregation, ALS, Alzheimer's disease, amyotrophic lateral sclerosis
Related Pathwaysautophagy pathway, Aβ accumulation
Linked Hypotheses2 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (153)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Purinergic Signaling Polarization Control
Score: 0.71
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Noradrenergic-Tau Propagation Blockade
Score: 0.71
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Membrane Cholesterol Gradient Modulators
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Microglial Purinergic Reprogramming
Score: 0.70
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.70
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
← Prevpg 3/8Next →

Related Analyses (30)

Does TFEB dysfunction cause neurodegeneration or represent a
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40

See Also (15)

Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses

Knowledge Graph (12 edges)

TREM2 p.Q33X mutation causes lysosomal dysfunction
lysosomal dysfunction associated_with carcinoma
TDP-43 activates lysosomal dysfunction
GRN causes lysosomal dysfunction
MAPT causes lysosomal dysfunction
C9orf72 causes lysosomal dysfunction
TBK1 prevents lysosomal dysfunction
C3 activates lysosomal dysfunction
RAC1 activates lysosomal dysfunction
TFEB activates lysosomal dysfunction

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.